Four times a year, the “Leica Scientific Forum — Advances in Life Science” offers top-class lectures, with eminently respectable speakers in the field of medicine like Noble prize winner Professor Dr. Erwin Neher from the Max-Planck-Institute for Biophysical Chemistry, Göttingen, who was guest speaker at the last Forum this year on December 5. The Forum – which takes place in Heidelberg…
Bio-imaging Facility at the University of Manchester ordered three new Nikon eC1 confocal microscopes.
Human genetic testing centre gains international quality accreditation.
Advia LabCell Modular Automation Systems integrate clinical chemistry, immunodiagnostics, haematology, urinalysis, and other hospital and laboratory areas.
The Leica DMD108 has been designed to ease the growing workload in histopathology laboratories.
A new blood test is under development that has detected two kinds of proteins found in people suffering Alzheimer's.
Rigel Medical, part of the Seaward Group, has launched a new biomedical electrical safety analyser.
Inverness Medical Innovations develops and manufactures rapid diagnostic products for use in preventive as well as interventional therapies.
Community-acquired pneumonia (CAP) is a major health problem globally. A new test now quickly identify pathogens. BinaxNOW tests quickly identify pathogens
Researchers have made a significant new discovery about how cells copy their genetic information accurately and efficiently to avoid cancers and other diseases.
Professor Werner Schlake, President of the German professional association of pathologists, described teleconsultation as the most significant application of telepathology.
By Professor Gustav Steinhoff MD, director of the Department for Cardiac Surgery, and Christof Stamm MD, co-ordinator of clinical studies, at Rostock University, Germany
Surgeons Sergey V Stonogin, specialist in infectious cases, Eugeny V Dvorovenko, Head of Emergency Surgery, and Vladimir A Chaplin, endoscopy specialist - report on results from their study to assess the most effective, safe combination of antibiotics to treat patients with acute appendicitis complicated by chickenpox
Bologna - The University Hospital S.Orsola-Malpighi has 1,800 beds and is one of the largest to install the DNLab management system. With 150 workstations connected to the LIS and over 50 analysers, each day, the two laboratories (central and microbiology) receive almost 3,000 orders and carry out over nine million tests annually. Hospital wards and departments are connected via Web to the LIS…
Access and monitoring of multiple lab instruments from a centralised location.
Rationale and effectiveness in the non-healing diabetic foot ulcer patient. By Peter HJ Mueller and Robert A Warriner III
To establish which materials allow pathogens to survived best, micro-organisms such as bacteria living in wet and dry environments, pathogenic fungi and the bacterium Escherichia coli, have been studied during comparative tests undertaken at the Hygiene Institute of the University of Leipzig.
About 25,000 German children are diabetic, and numbers are increasing rapidly. Specialists in childhood diabetes gathered at a meeting held by the Dianino Foundation during the 41st Annual Meeting of German Diabetes Society (DDG), to discuss `Diabetes-Nanni´, a programme in which female diabetes advisers receive additional psychology training to care for diabetes-affected families in their homes.…
You are invited to be part of a forum to bring respiratory biological research together, to discuss and build. Ours is a growing and vital discipline.
USA - A new laboratory test - EGFRx, developed by the Weisenthal Cancer Group* - has accurately identified patients who would benefit from treatment with the molecularly-targeted anti-cancer therapies gefitinib (Iressa, AstraZeneca) and erlotinib (Tarceva, Genentech), according to clinical data published at the annual meeting of the American Society of Clinical Oncology (ASCO).
USA - A new technology, named glycan microarray, can identify pathogens in a few hours and give advance warning of the ability of a virus to infect humans.
The Innsbruck Biocentre, led by Professor Lukas Huber, is involved in a major European research project. This involves the development of a 'biological interface' for a new semiconductor developed by Siemens.
